Trial Profile
Aleglitazar +/- atorvastatin, rosuvastatin in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Apr 2011
Price :
$35
*
At a glance
- Drugs Aleglitazar (Primary) ; Atorvastatin; Rosuvastatin
- Indications Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Diabetic nephropathies; Heart failure; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Hypolipoproteinaemia; Neurological disorders; Retinal vascular occlusion; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Roche
- 05 Nov 2010 New trial record.